| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY
1Hypertension and Vascular Research Center and 3Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and 2Department of Nephrology, Pontificia Universidad Catolica de Chile, Santiago, Chile
Submitted 15 July 2007 ; accepted in final form 29 October 2007
The present study was designed to determine ANG peptide content [ANG I, ANG II, ANG-(1-7)], ACE2 mRNA, and the immunocytochemical distribution of ANG-(1-7) and ACE2 in the uteroembryonic unit during early and late gestation in Sprague-Dawley rats and in a rat model of pregnancy-induced hypertension, the reduced uterine perfusion pressure (RUPP) model. At early pregnancy ANG-(1-7) and ACE2 staining were localized in the primary and secondary decidual zone and luminal and glandular epithelial cells. During late gestation, ANG-(1-7) and ACE2 staining was visualized in the labyrinth placenta and amniotic and yolk sac epithelium. Uterine ANG II concentration at early pregnancy was significantly decreased by 21–55% in the implantation and interimplantation sites compared with virgin rats, whereas ANG-(1-7) levels were maintained at prepregnancy levels. At late gestation, uterine concentrations of ANG I and ANG II were significantly increased (30% and 25%, respectively). In RUPP animals, ANG-(1-7) concentration is significantly reduced in the uterus (181 ± 16 vs. 372 ± 74 fmol/g of tissue) and placenta (143 ± 26 vs. 197 ± 20 fmol/g of tissue). ACE2 mRNA increased in the uterus of early pregnant compared with virgin rats, yet within the implantation site it was downregulated. At late pregnancy, ACE2 mRNA is elevated by 58% in the uterus and decreased by 59% in RUPP animals. The regulation of ANG-(1-7) and ACE2 in early and late pregnancy supports the hypothesis that ANG-(1-7) and ACE2 may act as a local autocrine/paracrine regulator throughout pregnancy, participating in the early (angiogenesis, apoptosis, and growth) and late (uteroplacental blood flow) events of pregnancy.
renin-angiotensin system; implantation
This article has been cited by other articles:
|
|
 |
|
  C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vaz-Silva, M.M. Carneiro, M.C. Ferreira, S.V.B. Pinheiro, D.A. Silva, A.L. Silva Filho, C.A. Witz, A.M. Reis, R.A. Santos, and F.M. Reis The Vasoactive Peptide Angiotensin-(1--7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium Reproductive Sciences, March 1, 2009; 16(3): 247 - 256. [Abstract] [PDF]
|
|
|
|
 |
|
 F. C Luft Renin-angiotensin system-related highlights from the High Blood Pressure Research Conference annual meeting Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 242 - 247. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Levy, Y. Yagil, M. Bursztyn, R. Barkalifa, S. Scharf, and C. Yagil ACE2 expression and activity are enhanced during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1953 - R1961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Brosnihan, J. B. Hodgin, O. Smithies, N. Maeda, and P. Gallagher Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-{alpha} knock-out mice Exp Physiol, May 1, 2008; 93(5): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gilbert, B. B. LaMarca, and J. P. Granger ACE2 and ANG-(1-7) in the gravid uterus: the new players on the block Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R915 - R916. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
